NEPT Share Price

Open 1.08 Change Price %
High 1.09 1 Day -0.01 -0.92
Low 1.06 1 Week 0.02 1.89
Close 1.08 1 Month 0.00 0.00
Volume 47279 1 Year 0.04 3.85
52 Week High 1.53
52 Week Low 0.86
NEPT Important Levels
Resistance 2 1.11
Resistance 1 1.10
Pivot 1.08
Support 1 1.06
Support 2 1.05
NASDAQ USA Most Active Stocks
DRYS 2.24 -4.68%
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
ACAS 17.99 0.39%
ASTI 0.00 0.00%
More..
NASDAQ USA Top Gainers Stocks
MYRX 0.10 100.00%
LOCM 0.09 50.00%
CEMP 4.05 28.57%
WRES 0.09 28.57%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
SKBI 0.10 25.00%
IPCI 2.55 18.60%
QKLS 0.15 15.38%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
GMETP 0.70 -59.54%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
EDMC 0.01 -50.00%
QTWW 0.08 -50.00%
SPIR 0.01 -50.00%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
More..

Neptune Technologies & Bioresources Inc (NASDAQ: NEPT)

NEPT Technical Analysis 3
As on 24th Feb 2017 NEPT Share Price closed @ 1.08 and we RECOMMEND Buy for LONG-TERM with Stoploss of 1.06 & Buy for SHORT-TERM with Stoploss of 1.04 we also expect STOCK to react on Following IMPORTANT LEVELS.
NEPT Target for February
1st Target up-side 1.23
2nd Target up-side 1.34
3rd Target up-side 1.45
1st Target down-side 0.93
2nd Target down-side 0.82
3rd Target down-side 0.71
Neptune Technologies & Bioresources Inc ( NASDAQ USA Symbol : NEPT )
Sector : N/AIndustry:N/AFull Time Employees:10Business Summary Neptune Technologies & Bioressources Inc., a biotechnology company, focuses on the research, development, and commercialization of products derived from marine biomasses for the nutraceutical and And Other Stocks in Same Sector
NEPT
1.08 -0.01 (-0.92 %)
LT : Buy
ST : Buy
NEPT Other Details
Segment EQ
Market Capital 223633584.00
Sector N/AIndustry:N/AFull Time Employees:10Business Summary Neptune Technologies & Bioressources Inc., a biotechnology company, focuses on the research, development, and commercialization of products derived from marine biomasses for the nutraceutical and
Industry N/AFull Time Employees:10Business Summary Neptune Technologies & Bioressources Inc., a biotechn
Offical website http://www.neptunebiotech.com
NEPT Address
NEPT
545 Promenade du Centropolis
Suite 100
Laval, QC H7T 0A3
Canada
Phone: 450-687-2262
Fax: 450-687-2272
NEPT Latest News
Acasti Pharma announces pricing for its public offering of units   Reuters Key Development   - 11th Feb 17
Neptune to buy 2.4 pct stake in Bluehole   Reuters Key Development   - 31st Jan 17
Acasti Pharma Q3 loss C$0.22/shr   Reuters Key Development   - 13th Jan 17
Neptune Qtrly revenues reached $12.3 mln, up 122 pct versus last year   Reuters Key Development   - 13th Jan 17
Acasti Pharma announces proposed offering of units   Reuters Key Development   - 06th Dec 16
Enzymotec qtrly non-gaap earnings per share $0.03   Reuters Key Development   - 16th Nov 16
Neptune and Ingenutra signs exclusive worldwide agreement for MaxSimil   Reuters Key Development   - 07th Oct 16
Here's Why Aurinia Pharmaceuticals, Georgetown Bancorp, and Three Other Stocks ...   Insider Monkey (blog)   - 06th Oct 16
Neptune and Aker BioMarine reach patent agreement   Reuters Key Development   - 03rd Oct 16
Richard Schottenfeld reports 5.4 pct stake in Neptune Technologies & Bioressources   Reuters Key Development   - 23rd Jul 16
Interactive Technical Analysis Chart Neptune Technologies & Bioresources Inc ( NEPT NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Neptune Technologies & Bioresources Inc
NEPT Business Profile
Neptune Technologies & Bioressources Inc. (Neptune) is a biotechnology company. The Company is engaged primarily in the development, manufacture and commercialization of marine-derived omega-3 polyunsaturated fatty acids (PUFAs). The Company operates in three segments: Neptune, Acasti Pharma Inc. and Acasti Pharma Inc. Its Neptune produces and commercializes nutraceutical products. Its Acasti Pharma Inc. develops and commercializes pharmaceutical applications for cardiovascular diseases. Its NeuroBioPharm Inc. develops and commercializes pharmaceutical applications for neurological diseases. It produces omega-3 PUFAs through its patented process of extracting oils from Antartic krill, which omega-3 PUFAs are then principally sold as bulk oil to Neptune�s distributors who commercialize them under their private label primarily in the United States, European and Australian nutraceutical markets. The Company�s products include Neptune Krill Oil (NKO) and ECOKRILL Oil (EKO).